New Zealand drugs regulator approves use of MDMA to treat severe PTSD

Image: The Guardian
ad slot · in-content video 16:9
Coverage
Wires & papers of record
- New Zealand decision follows Australian approval in 2023 of psychedelics to treat PTSD and treatment-resistant depression Two psychiatrists in New Zealand won approval on Friday to prescribe pharmaceutical-grade MDMA to people with severe post-traumatic stress disorder (PTSD). The move by New…